NeoGenomics, Inc. Forecasted to Earn Q1 2022 Earnings of ($0.31) Per Share (NASDAQ:NEO)
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) – Research analysts at SVB Leerink cut their Q1 2022 EPS estimates for shares of NeoGenomics in a note issued to investors on Monday, March 28th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn ($0.31) per share for the quarter, down from their […]